Short Interest in Better Therapeutics, Inc. (NASDAQ:BTTX) Declines By 14.9%

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report) saw a significant decline in short interest in the month of September. As of September 15th, there was short interest totalling 227,100 shares, a decline of 14.9% from the August 31st total of 267,000 shares. Currently, 1.1% of the company’s shares are sold short. Based on an […]

Related Keywords

Andrewj Armanino ,Davidp Perry , ,Better Therapeutics Inc ,Vanguard Group Inc ,Geode Capital Management ,Nasdaq ,Better Therapeutics Company Profile ,Securities Exchange Commission ,Better Therapeutics ,Get Free Report ,Chairman David ,Exchange Commission ,Director Andrew ,Capital Management ,State Street Corp ,Street Capital ,Better Therapeutics Daily ,Nasdaq Bttx ,Bttx ,Medical ,Stocks ,Options ,Put ,Call ,